al if you notice any of the following signs of a sudden life-threatening allergic reaction:
chills, fever, fast heart beat, wheezing or coughing, difficulty breathing, dizziness, flushing, sweating and swelling of the face, tongue or other parts of the body.
Other side effects not listed above may occur in some patients. Tell your doctor or nurse if you notice anything that is making you fell unwell.
Do not be alarmed by this list of possible side effects.
You may not experience any of them.
After using Vumon
The benefits and side effects of Vumon may take some time to occur. Therefore even after you have finished your Vumon treatment you should tell your doctor immediately if you notice any of the side effects listed.
Storage
Vumon will be stored in the pharmacy or on the ward. The injection is kept in a cool, dry place, protected from light, where the temperature stays below 25°C.
Product description
What it looks like
Vumon injection: Clear, faintly yellow to yellow solution in clear glass ampoules
Ampoules each contain 50 mg teniposide in 5 mL solution. AUST R 19286
Ingredients
Active ingredient:
teniposide
Other ingredients:
benzyl alcohol
dimethylacetamide
PEG-35 castor oil
maleic acid
ethanol
Distributed by
Bristol-Myers Squibb Pharmaceuticals, a division of
Bristol-Myers Squibb Australia Pty Ltd
556 Princes Highway
Noble Park VIC 3174
Date of preparation: 31st March 2011
AU_CMI_Vumon_V2.0_31Mar11.docx.
|
